Several studies have demonstrated the ability of oral Salmonella vaccines to inhibit tumor growth in mouse models [24,30,31] and, further, to be safe and immunogenic, as was shown in at least one clinical trial, which used an anti-VEGFR-2 vaccine VXM01 in patients with pancreatic cancer [32,33]. Here, KDR is linked to pancreatic neoplasm.